Medically Reviewed Content
Written by Rob Anderson, Health Technology Researcher & Medical Content Specialist. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting any medication.
One of the most common questions when starting Ozempic or Wegovy: “How much weight should I be losing, and when?” Here’s a realistic, data-backed breakdown of what to expect week by week — and what’s normal vs what might indicate the medication isn’t working for you.
Ozempic / Wegovy Weight Loss by Week: What the Trials Show
| Timepoint | Average Weight Loss (STEP-1, Wegovy 2.4mg) | What’s Happening |
|---|---|---|
| Weeks 1–4 | ~1–3 lbs | 0.25mg starting dose — primarily tolerability; some early appetite suppression |
| Weeks 5–8 | ~4–7 lbs total | 0.5mg dose — appetite suppression begins meaningfully |
| Weeks 9–16 | ~7–12 lbs total | Dose escalation; weight loss accelerating |
| Weeks 17–28 | ~12–20 lbs total | At or approaching 2.4mg maintenance dose; peak rate of loss |
| Weeks 28–52 | ~20–30 lbs total | Continued loss but rate slowing; plateau risk begins |
| Week 68 (end of STEP-1) | ~34 lbs average (14.9% body weight) | Full trial endpoint; ~35% lost 20%+ of body weight |
These are averages across all trial participants. Individual results vary significantly based on starting weight, dose reached, diet, exercise, and biological response to the medication. Some patients lose 5% of body weight; others lose 25%+.
Realistic Week-by-Week Expectations
Weeks 1–4: The Initiation Phase
At 0.25mg, many patients notice reduced appetite but minimal scale movement. This is normal. The starting dose is intentionally sub-therapeutic — it exists to let your body adjust to the medication before escalating. Don’t judge whether Ozempic is “working” during this phase. Focus on tolerating the medication and beginning healthy habits.
Weeks 5–12: Early Results
At 0.5mg–1mg, most patients notice clear appetite suppression. Food cravings diminish. Portions naturally shrink. The scale starts moving — typically 0.5–2 lbs/week at this stage. If you’re eating substantially fewer calories and not seeing movement by week 8–10, discuss with your prescriber whether dose escalation is appropriate sooner.
Weeks 13–20: Peak Loss Rate
Approaching the therapeutic dose range (1.7mg–2.4mg for Wegovy), most patients experience their fastest rate of weight loss. It’s common to lose 1–2 lbs/week consistently during this phase when dietary habits are solid. Energy levels often improve as weight comes down and blood sugar stabilizes.
Months 6–18: Slowing and Plateau
Weight loss naturally slows after 6–9 months as the body adapts. The plateau is real and expected — it’s not medication failure. The body fights back against weight loss through reduced metabolic rate and increased hunger signaling. Strategies to push through: increase protein intake, add or intensify resistance training, review calorie intake honestly, and consider whether dose is at maximum tolerated level.
How to Know If Ozempic Is Working for You
| Sign | What It Means |
|---|---|
| Reduced appetite, smaller portions feel satisfying | Medication working as intended |
| Food “noise” (constant food thoughts) quieter | Strong response to GLP-1 appetite suppression |
| Scale moving 0.5–2 lbs/week at therapeutic dose | Good progress; on track |
| No appetite change after 8+ weeks at 0.5mg+ | May be a non-responder at current dose; discuss escalation |
| Weight stable or increasing despite medication | Evaluate diet honestly; consider higher dose or medication change |
Non-Responders: Do They Exist?
Yes — approximately 10–15% of patients in clinical trials fail to achieve meaningful weight loss on semaglutide. Reasons include: biological variation in GLP-1 receptor sensitivity, compensatory eating behaviors, inadequate dose titration, or concurrent medications that promote weight gain. If you’re not seeing results after 12–16 weeks at maximum tolerated dose, discuss with your prescriber whether tirzepatide or another approach may be better suited.
Comparing Ozempic vs Wegovy Weight Loss Results
| Medication | Max Dose | Average Weight Loss | Trial |
|---|---|---|---|
| Ozempic 0.5mg | 0.5mg/week | ~4–5% body weight | SUSTAIN trials |
| Ozempic 1mg | 1mg/week | ~6–7% body weight | SUSTAIN trials |
| Ozempic 2mg | 2mg/week | ~9–10% body weight | SUSTAIN-11 |
| Wegovy 2.4mg | 2.4mg/week | ~15% body weight | STEP-1 |
Frequently Asked Questions
How much weight can I lose in 3 months on Ozempic?
At 3 months (12 weeks), most patients have completed dose escalation to 0.5mg–1mg and are beginning to see meaningful results. Typical 3-month weight loss ranges from 5–15 lbs, though individuals vary widely. The faster losses come at higher doses reached later in treatment.
Why am I not losing weight on Ozempic?
The most common reasons: still at the starting dose (0.25mg) which is sub-therapeutic, compensating by eating more calorie-dense foods even in smaller portions, being a partial non-responder requiring a higher dose, or taking medications that counteract weight loss effects. Track calories honestly for 1–2 weeks to rule out dietary compensation.
Do you lose weight faster on Wegovy than Ozempic?
Yes, typically. Wegovy’s 2.4mg dose is higher than Ozempic’s maximum of 2mg for diabetes, and Wegovy’s clinical trials (designed specifically for obesity) show greater average weight loss (~15%) than Ozempic studies in diabetic populations (~6–10%).
Is losing 1 lb per week on Ozempic good?
Yes — 1 lb/week at a therapeutic dose is solid, consistent progress. Over a year, that’s 50+ lbs. Some patients lose faster early and slower later; others have a steadier pace throughout. The total loss over 12–18 months matters more than weekly fluctuations.
Sources & References
- U.S. Food and Drug Administration (FDA) – Drug Approvals and Databases
- National Institutes of Health (NIH) – PubMed Medical Literature
- American Diabetes Association – Medication & Therapies
- Novo Nordisk – Clinical Research Data
- Eli Lilly – Medical Information
This content is regularly reviewed and updated to reflect the latest medical research and FDA guidance.
📋 Compare Top GLP-1 Providers — Find Your Best Option
